Bivalirudin during primary PCI in acute myocardial infarction

New England Journal of Medicine

Volumn 358, Issue 21, 2008, Pages 2218-2230

  Stone, Gregg W ^a   Witzenbichler, Bernhard ^b   Guagliumi, Giulio ^c   Peruga, Jan Z ^d   Brodie, Bruce R ^e   Dudek, Dariusz ^f   Kornowski, Ran ^g   Hartmann, Franz ^h   Gersh, Bernard J ⁱ   Pocock, Stuart J ^j   Dangas, George ^a   Wong, S Chiu ^k   Kirtane, Ajay J ^a   Parise, Helen ^a   Mehran, Roxana ^a  

^a NewYork Presbyterian Hospital   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c OSPEDALI RIUNITI   (Italy)

^d Department of Radiology   (Poland)

^e MOSES H CONE MEMORIAL HOSPITAL   (United States)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g RABIN MEDICAL CENTER   (Israel)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ MAYO CLINIC   (United States)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k WEILL CORNELL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; TICLOPIDINE;

ACUTE HEART INFARCTION; ACUTE STENT THROMBOSIS; ADULT; ADVERSE OUTCOME; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DEATH; DRUG ELUTING STENT; DRUG FATALITY; FEMALE; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEMATOMA; HUMAN; INJECTION SITE BLEEDING; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REVASCULARIZATION; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION; STROKE; THROMBOSIS; TREATMENT OUTCOME;

EID: 44249122195     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0708191     Document Type: Article

References (30)

1. EC Keeley JA Boura CL Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 2003 13 20
2. A Schomig FJ Neumann A Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334 1996 1084 1089
3. GW Stone CL Grines DA Cox Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med 346 2002 957 966
4. G De Luca H Suryapranata JP Ottervanger Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Int J Cardiol 119 2007 306 309
5. G De Luca H Suryapranata GW Stone D Antoniucci FJ Neumann M Chiarello Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 153 2007 343 353
6. AM Ross RJ Gibbons GW Stone RA Kloner RW Alexander A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 2005 1775 1780
7. PW Armstrong CB Granger PX Adams Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297 2007 43 51
8. JH Alexander HR Reynolds AL Stebbins Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297 2007 1657 1666
9. G De Luca H Suryapranata GW Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 2005 1759 1765
10. DE Kandzari V Hasselblad JE Tcheng Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J 147 2004 457 462
11. HL Dauerman PD Frederick D Miller WJ French Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction. Coron Artery Dis 18 2007 141 148
12. KA Fox PG Steg KA Eagle Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 297 2007 1892 1900
13. G Montalescot P Barragan O Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 2001 1895 1903
14. DJ Kereiakes SD Berkowitz AM Lincoff Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. Am Heart J 140 2000 74 80
15. E Nikolsky CL Grines DA Cox Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 99 2007 1055 1061
16. JW Eikelboom SR Mehta SS Anand C Xie KA Fox S Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 2006 774 782
17. TD Kinnaird E Stabile GS Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 2003 930 935
18. SV Rao JG Jollis RA Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 2004 1555 1562
19. SV Manoukian F Feit R Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 49 2007 1362 1368
20. AM Lincoff JA Bittl RA Harrington Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 2003 853 863 [Erratum, JAMA 2003;289:1638.]
21. AM Lincoff NS Kleiman DJ Kereiakes Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 292 2004 696 703 [Erratum, JAMA 2006;296:46.]
22. GW Stone BT McLaurin DA Cox Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 2006 2203 2216
23. GW Stone JH Ware ME Bertrand Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA 298 2007 2497 2506
24. GW Stone M Bertrand A Colombo Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. Am Heart J 148 2004 764 775
25. DE Cutlip S Windecker R Mehran Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 2007 2344 2351
26. Y Benjamini Y Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc [B] 57 1995 289 300
27. F Feit MD Voeltz MJ Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention: an analysis of the REPLACE-2 trial. Am J Cardiol 100 2007 1364 1369
28. PA Gurbel KP Bliden KA Zaman JA Yoho KM Hayes US Tantry Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation 111 2005 1153 1159
29. SD Wiviott E Braunwald CH McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 2007 2001 2015
30. AB Greenbaum EM Ohman CM Gibson Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial. Am Heart J 154 2007 702 709